Stay updated on Lebrikizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Lebrikizumab in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows a revision bump from v3.6.3 to v3.6.4, indicating a small software update with no visible changes to the study details content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.1 to Revision: v3.6.3, indicating a new revision of the page's metadata.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page revision label changed from v3.6.0 to v3.6.1, indicating a minor update to the page metadata. This likely represents a small patch or improvement without altering the study content.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page now signals that recruitment is closed with 'No longer looking for participants' and adds new help/join-related navigation items. The Publications section includes a new 2026 Lebrikizumab reference and the revision label updates to v3.6.0, while an older 'Intervention / Treatment' heading and a previous publication citation were removed.SummaryDifference0.2%

- Check82 days agoChange DetectedNew citation added for a 2026 Lebrikizumab efficacy study in atopic dermatitis and an earlier 2025 online-ahead-of-print citation was removed. The study record revision is updated to version 3.5.5.SummaryDifference0.0%

Stay in the know with updates to Lebrikizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.